Matthew Blischak
Chief Executive Officer at FINCH THERAPEUTICS GROUP, INC.
Net worth: - $ as of 30/04/2024
Matthew Blischak active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Chief Executive Officer | 16/05/2023 | - |
| President | 16/05/2023 | - | |
| Corporate Secretary | 16/05/2023 | - |
Career history of Matthew Blischak
Former positions of Matthew Blischak
| Companies | Position | Start | End |
|---|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/05/2018 | 01/04/2023 |
Training of Matthew Blischak
| Case Western Reserve University | Undergraduate Degree |
| American University Washington College of Law | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
Statistics
International
| United States | 5 |
| 2 |
Operational
| Graduate Degree | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
| Finch Therapeutics Group, Inc. | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Matthew Blischak
- Experience
